Sign In
Buy VKTX
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026
Merger Mania: 3 Potential Takeover Targets to Watch for Lucrative Buyouts
12:13pm, Tuesday, 02'nd Apr 2024
Reduced interest rates make it easier for firms to buy other companies. That's because acquiring firms can borrow the money needed to finance mergers and acquisitions (M&A) deals much more cheaply whe
Viking Therapeutics: Future Weight Loss Heavyweight?
06:01am, Tuesday, 02'nd Apr 2024
Viking Therapeutics' share price has rapidly increased from recent weight loss drug excitement. The company's value seems to be derived from its weight loss and NASH/MASH candidates. VK2735, the weigh
The 3 Best Biotech Stocks to Buy in April 2024
09:09pm, Monday, 01'st Apr 2024
Right now, biotech is one of the hottest sectors on the market, creating big opportunities for some of the best biotech stocks to buy in April. All of this is thanks to new innovation, millions of ret
Healthcare stocks fade as obesity-drug optimism fades
08:59pm, Monday, 01'st Apr 2024
Healthcare companies fell sharply Monday as ebullience about a new class of weight control drugs subsided.
Viking Therapeutics Stock Has 72% Upside, According to 1 Wall Street Analyst
01:49pm, Monday, 01'st Apr 2024
Viking Therapeutics is a clinical-stage biotechnology company developing a weight management candidate. Viking Therapeutics' weight management candidate, VK2735 is similar to the active ingredient in
Viking Therapeutics Stock Has 72% Upside, According to 1 Wall Street Analyst
01:49pm, Monday, 01'st Apr 2024
Viking Therapeutics is a clinical-stage biotechnology company developing a weight management candidate. Viking Therapeutics' weight management candidate, VK2735 is similar to the active ingredient in
Prediction: Pfizer Won't Acquire Viking Therapeutics. Here's Why.
09:31am, Sunday, 31'st Mar 2024
Viking Therapeutics may be on the verge of a breakthrough obesity care treatment. Right now, obesity care and diabetes are dominated by Novo Nordisk and Eli Lilly.
Why Eli Lilly And Rival Novo Nordisk Won't Be Troubled By Viking's Latest Weight Loss Data
02:10am, Sunday, 31'st Mar 2024
Eli Lilly and Novo Nordisk have created what Wall Street believes will be the biggest ever pharmaceutical market with its miraculous weight loss drugs. Novo Nordisk's Ozempic and Wegovy, as well as El
The 3 Best Russell 2000 Stocks to Buy in Q2 2024
01:44pm, Saturday, 30'th Mar 2024
The Russell 2000 index offers investors various small-cap companies that can incite great long-term returns and add a more differentiated investment to their portfolio. Not all stocks in the Russell 2
Is It Too Late to Buy Viking Therapeutics Stock?
09:15am, Friday, 29'th Mar 2024
Excitement over its weight-loss drug candidate has made the stock a hot buy this year. Last week, the shares got a further boost from clinical trial data for a pill version of VK2735.
Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals
09:00am, Friday, 29'th Mar 2024
Viking's drug candidate has shown promise in clinical studies as a potential weight loss medicine. Madrigal just launched the first (and so far only) medicine approved by the U.S. for NASH.
Why Viking Therapeutics Stock Was Rocketing Higher This Week
08:51am, Friday, 29'th Mar 2024
The biotech concluded an encouraging early-stage trial of its weight-loss drug candidate. It successfully tested a tablet version of the treatment.
This small-cap stock is expected to take off — if its weight-loss pill trial succeeds
03:02pm, Thursday, 28'th Mar 2024
The stock of small-cap Terns Pharmaceuticals Inc. rose 6% on Thursday, amid bullish analyst comment on the company's pipeline, which includes an oral treatment for obesity that one bank believes could
2 Top Biotech Buyout Candidates
02:56pm, Thursday, 28'th Mar 2024
After a strong resurgence in the back half of 2023 and continued momentum into the first quarter of 2024, biotech stocks are back in vogue. “Hawkish” Federal Reserve Policy, a brutal bear market i
3 stocks to turn $100 into $1,000 in April
07:20am, Thursday, 28'th Mar 2024
Despite the general fears that the retaining of high interest rates could spark a recession and severely damage the stock market, the situation has been the opposite for the most part in 2024.
